Durham, NC, United States of America

Michael D Nichols

This inventor holds 2 USPTO granted patents. Top assignees: Duke University, Washington University. Active years: 2013-2023.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael D. Nichols: Innovator in Biomedical Applications

Introduction

Michael D. Nichols is a prominent inventor based in Durham, NC (US), known for his contributions to biomedical applications. With a total of two patents, Nichols has made significant strides in the field of live cell identification and microparticle formation.

Latest Patents

Nichols' latest patents include "Antidote-mediated reversal of extracellular aptamer staining" and "Hydrogel microparticle formation in aqueous solvent for biomedical applications." The first patent provides compositions and methods for sorting and identifying live cells, allowing for the staining of live cells with aptamers to identify specific cells within a heterogeneous population. The second patent focuses on the formation of microparticles comprising cross-linked water-soluble polymers, which can be utilized in various biomedical applications, including coatings and scaffolds.

Career Highlights

Throughout his career, Nichols has worked with esteemed institutions such as Washington University and Duke University. His work has contributed to advancements in biomedical research and applications, showcasing his expertise in the field.

Collaborations

Nichols has collaborated with notable individuals, including Donald Leo Elbert and Evan A. Scott, further enhancing his research and innovation efforts.

Conclusion

Michael D. Nichols stands out as an influential inventor in the biomedical field, with his patents reflecting innovative approaches to live cell identification and microparticle technology. His contributions continue to impact the scientific community and advance biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…